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The neuronal membrane is the site where most processes involved
in neuronal preservation and functioning are triggered. These
actions require the participation of membrane-related molecular
agents, which associate in protein/lipid clusters to initiate molec-
ular processing and signal transduction. Furthermore, numerous
neuropathological phenomena have their origin in this structure
and/or are a consequence of membrane dysfunctioning (Lukiw,
2013). Even though the precise molecular mechanisms to pre-
serve “membrane health” are unclear in most cases, it seems that
the effects of different lipids on the microstructural and stoi-
chiometric properties of the membrane influence the behavior
and association of proteins within the lipid environment, which
determine the final cell response.
This Special issue composed by five outstanding Reviews and
a very interesting Hypothesis and Theory work tackles differ-
ent strategies and events taking place at the neuronal membrane
related to neurodegeneration and neuroprotection against the
most common form of dementia in the elderly, Alzheimer’s
disease (AD) and Parkinson’s disease (PD). These diseases are
characterized by pathological protein aggregates in particular
brain areas leading to selective neurodegeneration that explains
their clinical phenotypes. Related to AD, one of the main neu-
ropathological hallmarks courses with amyloid beta [Aβ peptide
formation, produced by amyloid precursor protein (APP) prote-
olysis, through the action of two secretases: β-secretase (BACE)
and γ-secretase]. In particular, BACE1 is the main responsible
for Aβ generation, and is therefore considered a major drug tar-
get for AD. However, as reviewed in Dislich and Lichtenthaler
(2012), BACE1 also catalyzes the proteolysis of other different
substrates still not well-characterized, and whose identification
is crucial to develop better pharmacological strategies targeting
this molecule. Another important aspect awaiting clarification is
related to the involvement of membrane lipids in BACE1 reg-
ulation. Thus, this enzyme can be palmitoylated, and anchored
into lipid raft microstructures by GPI binding, also observing
an important influence on BACE1 activity and Aβ produc-
tion depending on cholesterol levels (Dislich and Lichtenthaler,
2012).
Thus, cholesterol is crucial to keep the neuronal membrane
architecture stable, and failures in cholesterol homeostasis con-
tribute to progressive neurodegeneration (reviewed in Anchisi
et al., 2013). Cholesterol is an essential component of myelin,
and it is thereby required for brain growth, differentiation, and
preservation. This sterol also participates in the particular com-
position of membrane raft microdomains, which are main sites
of protein signaling clusters related to neuroprotection (reviewed
in Marin, 2011). Even though cholesterol is mainly found free in
the brain, the small proportion (∼5%) of esterified cholesterol
is modulated by brain growth and increase myelination, evoking
the exquisite regulation of this sterol. Indeed, cholesterol impair-
ment in the neuronal membrane has been related, among others,
to AD, prion diseases and autistic spectrum disorders, as it has
been nicely illustrated by Anchisi et al. (2013). Furthermore, an
important factor of cholesterol production and trafficking is due
to the activity of low density lipoprotein receptor-related pro-
teins (LRP1 and LRP2) which regulate cholesterol uptake into the
neuron. Even though LRPs can bind to numerous extracellular
ligands, their main role is related to metabolism of cholesterol
associated with ApoE-containing lipoproteins, which influences
the development of AD neuropathology (reviewed in Spuch et al.,
2012). Moreover, LRPs can interact with APP, thereby promoting
Aβ formation, and also participate in endocytic and internaliza-
tion processing of ApoE, APP, and Aβ. Overall, LRPs have an
important contribution to amyloid metabolism and accumula-
tion which is worthy to explore. Other receptors known to bind
Aβ oligomers are found at the postsynaptic membrane of exci-
tatory synapses, and could be responsible for their neurotoxic
effects. Among the Aβ potential targets are glutamate receptors,
neurotrophin receptors, neuroligin, and other receptors that have
been summarized inDinamarca et al. (2012) review. In particular,
further characterization of Aβ binding to neuroligin in a domain
homologous to acetylcholinesterase may importantly contribute
to understanding AD pathological mechanisms.
Related to PD, a dementia characterized by loss of cognitive
skills and motor impairment, a main pathological hallmark is the
aberrant aggregation of cytosolic α-synuclein (α-Syn) that cul-
minates in neuronal death. However, emerging data have found
extracellular aggregates of α-Syn, evoking a similar toxic pattern
than Aβ, although their pathological actions are still unknown.
One of the interesting purposed hypotheses exposed by Pacheco
et al. (2012) is that extracellular α-Syn oligomers may form
pores/perforations at the neuronal membrane which may pro-
voke membrane disruption, thereby inducing neuronal impair-
ments. Pacheco et al.’s work also provides a nice description of
different pathways for unconventional exocytosis of soluble and
aggregated α-Syn. These new insights will be worth to explore in
order to unravel the pathological events leading to PD.
Last, but not least, related to brain friends, the work by
Fiocchetti et al. (2012) brings us some hints on the neuropro-
tective actions of estradiol involving estrogen receptor beta (ERβ
actions at the plasma membrane). Rapid signaling through this
receptor has been poorly characterized so far, but novel findings
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indicate that ERβ-relatedmechanisms are required for hippocam-
pal synaptic plasticity. Moreover, part of ERβ signal transduction
involves neuroglobin activities, which displays a brain protec-
tive function. Further work is required to characterize this novel
mechanism of neuroprotection related to learning and memory
preservation.
We hope this Issue will be a source of inspiration for FMPB
readers.
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